| HOME >> MEDICINE >> TECHNOLOGY |
Table 141: Endoceutics' Included Breast Cancer Drugs and Competitive Fall-Out 1163
Table 142: Enkam Pharmaceuticals' Included Breast Cancer Drugs and Competitive Fall-Out 1165
Table 143: EntreMed's Included Breast Cancer Drugs and Competitive Fall-Out 1167
Table 144: Enzon's Included Breast Cancer Drugs and Competitive Fall-Out 1170
Table 145: Epeius Biotechnologies' Included Breast Cancer Drugs and Competitive Fall-Out 1172
Table 146: EpiCept's Included Breast Cancer Drugs and Competitive Fall-Out 1176
Table 147: Epizyme's Included Breast Cancer Drugs and Competitive Fall-Out 1178
Table 148: Esperance Pharmaceuticals' Included Breast Cancer Drugs and Competitive Fall-Out 1180
Table 149: Etubics' Included Breast Cancer Drugs and Competitive Fall-Out 1184
Table 150: Eucodis' Included Breast Cancer Drugs and Competitive Fall-Out 1187
Table 151: Exelixis' Included Breast Cancer Drugs and Competitive Fall-Out 1191
Table 152: Expression Drug Designs' Included Breast Cancer Drugs and Competitive Fall-Out 1196
Table 153: Formula Pharmaceuticals' Included Breast Cancer Drugs and Competitive Fall-Out 1199
Table 154: Fresenius' Included Breast Cancer Drugs and Competitive Fall-Out 1203
Table 155: Galectin Therapeutics' Included Breast Cancer Drugs and Competitive Fall-Out 1206
Table 156: Galena Biopharma's Included Breast Cancer Drugs and Competitive Fall-Out 1211
Table 157: Genentech's Included Breast Cancer Drugs and Competitive Fall-Out 1216
Table 158: Generex's Included Breast Cancer Drugs and Competitive Fall-Out 1220
Table 159: Genmab's Included Breast Cancer Drugs and Competitive Fall-Out 1224
Table 160: Genta's Included Breast Cancer Drugs and Competitive Fall-Out 1227
Table 161: GenVec's Included Breast Cancer Drugs and Competitive Fall-Out 1229
Table 162: Geron's Included Breast Cancer Drugs
'/>"/>
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |